The prognostic value of [ 18 F]FDG PET/CT texture analysis prior to transplantation for unresectable colorectal liver metastases
Clinical Physiology and Functional Imaging · 2025-01 · 45 (1)
DOI: 10.1111/cpf.12908 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Physiology and Functional Imaging, online erschienen am 02.10.2024. Verfasst von Nadide Mutlukoca Stern und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Vestre Viken Hospital Trust, Drammen, Norway. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Colorectal Neoplasms, Liver Neoplasms, Positron Emission Tomography Computed Tomography. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Vestre Viken Hospital Trust, Oslo University Hospital.
Abstract (Originalsprache)
Introduction
To determine whether heterogeneity in colorectal liver metastases (CRLM) 18 F fluorodeoxyglucose [ 18 F]FDG distribution is predictive of disease‐free survival (DFS) and overall survival (OS) following liver transplantation (LT) for unresectable CRLM.
Methods
The preoperative [ 18 F]FDG positron emission tomography/computed tomography examinations of all patients in the secondary cancer 1 and 2 studies were retrospectively assessed. Maximum standardized uptake value (SUV max ), metabolic tumour volume (MTV), and six texture heterogeneity parameters (joint entropy GLCM, dissimilarity GLCM, grey level variance SZM, size zone variance SZM, and zone percentage SZM , and morphological feature convex deficiency) were obtained. DFS and OS for patients over and under the median value for each of these parameters were compared by using the Kaplan Meier method and log rank test.
Results
Twenty‐eight out of 40 patients who underwent LT for unresectable CRLM had liver metastases with uptake above liver background and were eligible for inclusion. Low MTV ( p < 0.001) and dissimilarity GLCM ( p = 0.016) were correlated to longer DFS. Low MTV ( p < 0.001) and low values of the texture parameters dissimilarity GLCM ( p = 0.038), joint entropy GLCM ( p = 0.015) and zone percentage SZM ( p = 0.037) were significantly correlated to longer OS. SUV max was not correlated to DFS and OS.
Conclusion
Although some texture parameters were able to significantly predict DFS and OS, MTV seems to be superior to predict both DFS and OS following LT for unresectable CRLM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Vestre Viken Hospital Trust, Drammen, Norway.
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
- Department of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
- Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
- Department of Physics, University of Oslo, Oslo, Norway.
ORCID-Profile: Anselm Schulz
Förderung
- Vestre Viken Hospital Trust
- Oslo University Hospital
Zitieren
APA
Stern, N. M., Mikalsen, L. T. G., Dueland, S., Schulz, A., Line, P. D., Stokke, C., & Grut, H. (2025). The prognostic value of [ 18 F]FDG PET/CT texture analysis prior to transplantation for unresectable colorectal liver metastases. Clinical Physiology and Functional Imaging, 45(1). https://doi.org/10.1111/cpf.12908
Vancouver
Stern NM, Mikalsen LTG, Dueland S, Schulz A, Line PD, Stokke C, et al. The prognostic value of [ 18 F]FDG PET/CT texture analysis prior to transplantation for unresectable colorectal liver metastases. Clinical Physiology and Functional Imaging. 2025;45(1). doi:10.1111/cpf.12908
BibTeX
@article{Stern2025,
author = {Stern, Nadide Mutlukoca and Mikalsen, Lars Tore Gyland and Dueland, Svein and Schulz, Anselm and Line, Pål-Dag and Stokke, Caroline and Grut, Harald},
title = {The prognostic value of [ 18 F]FDG PET/CT texture analysis prior to transplantation for unresectable colorectal liver metastases},
journal = {Clinical Physiology and Functional Imaging},
year = {2025},
volume = {45},
number = {1},
doi = {10.1111/cpf.12908}
}
EUVIMED